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Background
Osteoporosis-osteopenia syndrome (OOS) is found in
more than 50% of thalassemia patients worldwide [1,2].
Despite appropriate management, thalassemics continue
to exhibit a decrease in bone mass due to the multifactor-
ial pathogenesis of OOS in thalassemia [3]. Therefore, this
study aims to obtain an insight on the thalassemia
patients' perception of OOS and possible lifestyle contri-
buting factors.
Methods
64 regularly transfused patients from 2 major Thalassae-
mia Clinics in Penang aged 10 years and above partici-
pated in a 6-week cross-sectional study using a self-
administered questionnaire. The questionnaire addressed
lifestyle factors (exercise, diet), awareness and symptoms
of bone problems. Bone profile information (serum levels
of calcium, phosphate, alkaline phosphatase (ALP),
25-hydroxyvitamin D (VitD), and Bone Mineral Density
T-scores [BMD]) from patients' records was documented.
OOS was considered based on either BMD (lumbar and
femur) of <-1.0 and/or VitD of <30ng/ml. Odds ratio was
used to compare the relationship between patients' under-
standing of OOS and presence of symptomatic bone pro-
blems. A p-value of <0.05 was taken as significant.
Results
25% of patients had good understanding of OOS in tha-
lassemia. 51.6% were symptomatic, namely 20.3% had
history of bone pain or fracture and 42.2% had heights
below the 5th percentile. 81.2% exercised frequently and
65.6% consumed low intake of dairy products.
Only 64% of patients had either one or both BMD and
VitD results. Of the available results, 87.5% had low
VitD and 86.2% had low BMD. Sample serum calcium
and phosphate levels were normal while the mean ALP
was 164mmol/l. A better understanding on OOS
reduced the odds of having symptomatic bone problems,
however this was not significant (OR=0.92; p>0.05).
Conclusion
Low-level VitD and BMD results were detected in over
80% of patients who had undergone an OOS diagnostic
investigation. This is consistent with the current literature
[1,2]. Many were unaware of OOS and the importance of
dairy intake. This suggests that OOS is not well known.
The results of this study were limited to the patient's abil-
ity to answer the questionnaire and the design of the ques-
tionnaire. T-scores were reported instead of Z-scores,
which would give a better reflection of OOS in adolescents
[4]. ALP could also be affected by other factors [5,6]. This
study has shown the presence of OOS and its risk among
the Penang adolescent thalassemia patients. Some were
symptomatic. Many were unaware of OOS and took mini-
mal dietary precaution. This calls for better education
about OOS, its detection and prevention for thalassemia
patients and health-care workers.
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